SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian S who wrote (25)4/26/1997 5:47:00 AM
From: Jim Mac   of 413
 
With today's approval of VisX astigmatism, LVCI's U.S. procedure count should jump by 50%+. Who wants to bet they'll be cash flow positive by CY97Q4, if not profitable? 150,000+ U.S. procedures this year, LVCI can do 10% at least. Fundamentals, strategies working out. MobilExcimer, astigmatism approval, growing demand for PRK...Stock oversold.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext